Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify a dose of P276-00 that can be safely administered
along with Gemcitabine and to examine safety and efficacy of the combination in treatment of
advanced pancreatic cancer.